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Abstract
International travel continues to increase in frequency. Health care providers need a wide understanding of the
spectrum of travel related diseases and their management. This retrospective study analyses the demographic
and clinical data of 360 travellers returning from the tropics presenting to an outpatient clinic at a tertiary hospital
between 2003 - 2007. The aim of this study was to analyse the frequency of presenting symptoms and diseases in
ill returning travellers and to correlate them to the areas visited and the duration and purpose of travel. The main
symptoms during travel were diarrhoea (n = 200, 56 %) and fever (n = 124, 34 %). Travellers not visiting friends and
relatives but with close contact to the local population were at more than two-fold increased risk of diarrhoea
(Odds Ratio [OR] 2.5; 95 % confidence interval [CI] 1.1-6.0, p = 0.03) and fever (OR 2.4; 95 % CI 1.1-5.3; p = 0.02)
compared to tourist travellers. Travellers visiting friends and relatives (VFR) were not at increased risk for diarrhoea
(OR 0.6; 95 % CI 0.3-1.3; p = 0.17), or fever (OR 1.5; 95 % CI 0.7-3.4; p = 0.28). Thirty-two percent of all travellers
(n = 115) were diagnosed with a specific pathogen. Malaria (6 %), giardiasis (6 %) and amebiasis (4 %) were the
most frequently detected pathogens. The odds of malaria as a cause of the presenting illness was lower among
travellers reporting pre-travel advice. Specific antimicrobial treatment was required in around one third of the
patients.
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Introduction
International tourist arrivals grew by 4.4 % in 2015 and
reached a total of 1,184 million in 2015 [1]. In Switzerland
alone, 1.5 million travel episodes to destinations outside of
Europe were recorded in 2014 [2]. There is a relative decline
in people travelling for tourism, while the proportion of trav-
ellers visiting friends and relatives is increasing [3]. Approxi-
mately 8 % of travellers require medical care during or after
their travel [4]. Diarrhoea and fever are the most frequent
health problems affecting travellers to developing countries
[5, 6]. Large surveillance studies report Asia and Sub-
Saharan Africa to be the most common regions where ill-
nesses are acquired [7]. Pre-travel advice is sought in varying
degrees in international travellers: 40 – 56 % in two large
series [8, 9]. We aimed to understand the specific issues of
returning Swiss travellers presenting to the Department of
Infectious Diseases at Bern University Hospital, Switzerland.
Therefore, the frequency of presenting symptoms and dis-
eases in ill returning travellers were analysed and correlated
to the areas visited and to the duration and purpose of travel.
Methods
The study was designed as a single centre descriptive
retrospective data analysis of travellers returning ill from
the tropics with a presumed travel-associated condition
seeking medical care at the outpatient clinic of the
Department of Infectious Diseases (ID) at the University
Hospital of Berne, Switzerland between 2003 – 2007. The
Infectious Disease department of University Hospital of
Berne is a tertiary care institution. Most patients are re-
ferred by their family physicians for a second opinion.
There are only two other physicians in the city with a spe-
cialisation in tropical diseases, therefore, for patients
returning ill from the tropics, the ID department also has
the role as a primary care institution.
The protocol of the study was reviewed and approved
by the Department of Teaching and Research of the
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University Hospital of Berne. In agreement with local legal
requirements at the start of the study, the protocol was
judged not to be subject to approval by a constituted
Competent Ethics Committee.
A predefined questionnaire was used to extract the data
from the patient’s files. Data were analysed using the
statistical package (StataSE11, StataCorp, College Station,
TX, USA). Descriptive statistical analysis was performed
and risk factors for different outcomes were evaluated
using chi-square statistics for categorical variables, and
parametric and non-parametric tests for numeric vari-
ables. We performed univariable logistic regression for
risk factors associated with illness during and after travel.
Stool samples were analysed as follows: a routine com-
mercial fecal concentrator system was used to provide
clean sediments for microscopic examination for the iden-
tification of helminth eggs and larvae, protozoan cysts,
coccidian oocysts, and microsporidian spores. Salmonella
spp., Shigella spp. and Campylobacter spp. were routinely
isolated by culture. For Giardia lamblia (intestinalis) and
Cryptosporidium spp. we used solid phase immunoassays
which detect Giardia specific antigen (GSA 65) respect-
ively Cryptosporidium specific antigen (CSA). In order to
distinguish between the pathogenic Entamoeba histolytica
and the apathogenic Entamoeba dispar (both are micro-
scopically indistinguishable) an enzyme immunoassay for
the rapid detection of the adhesion of E. histolytica was
used. For the detection of Clostridium difficile toxin and
the various toxins of pathogenic Echerichia coli (EPEC,
EHEC, ETEC, EIEC and EAEC) immunoassays and/or
polymerase chain reaction (PCR) were applied on demand.
Travellers were grouped into five geographic areas ac-
cording to their travel destinations: Latin America (LAM),
North Africa/Middle East (NAME), Sub-Saharan Africa
(SSA), Southeast and South Asia (SESA) and travellers who
had visited more than one area. Diarrhoea was defined as
three or more unformed bowel movements a day. Fever
was defined as a body temperature above 38.5 °C when
measured at our clinic. Fever during travel was self-
reported and not documented. Travellers were classified as
visiting friends and relatives (VFR) according to the follow-
ing criteria: a traveller whose primary purpose of travel is to
visit friends or relatives where there is a gradient of
epidemiological risk between home and destination [10].
Travellers were classified as having close contact to the
local population when they were either living with locals or
working within local communities (e.g. missionary or
volunteer aid worker). Travellers were further categorised
as tourists or as travellers for the purpose of work or study.
Results
The population included 360 travellers aged 11 to
82 years (mean: 35 years); 69 % were female. The major-
ity of patients in this study (254, 71 %) came to our
clinic for their first consultation after travelling while the
remaining 106 patients were referred from an external
doctor. One-hundred-twenty-eight (36 %) travellers
returned ill from SESA, 125 (35 %) from SSA, followed
by 83 (23 %) from LAM. Six travellers (2 %) travelled to
more than one of these regions. Travel purpose was
mainly for tourism (n = 210, 58 %), 31 (9 %) were VFR
and 30 (8 %) had close contact to the local population.
The median duration of travel was 30 days (range 5 -
540). The characteristics of ill returned travellers accord-
ing to the region visited are summarized in Table 1.
Symptoms and medical assistance during travel
Two hundred travellers (56 %) suffered from diarrhoea
during their trip. Self-reported fever was the second
most common complaint during travels (n = 124, 34 %).
Compared to tourists, travellers with close contact to
the population had a more than two-fold (OR 2.5; 95 %
CI 1.1-6.0, p = 0.03) increased odds of suffering from
diarrhoea and a 2.4-fold increased risk of having fever
(95 % CI 1.1-5.3; p =0.02) (Table 2). VFRs were not at
higher risk of suffering from fever or diarrhoea. Travel
of longer than three months was associated with a sig-
nificantly increased rate of diarrhoea, while the occur-
rence of fever increased with the length of stay up to
three months, but did not increase thereafter (Table 2).
Eighty out of the 360 travellers (23 %) sought medical
assistance during their trip, mainly people who had close
contact to the population (n = 11, 16 %; p = 0.06). Twenty
travellers (6 % of all travellers) who sought medical care
abroad were hospitalized. The main reasons for hospital-
isation were malaria (n = 7) and gastrointestinal disorders
(n = 6). Of the patients with gastrointestinal disorders two
were diagnosed with salmonellosis, one each with shigello-
sis, and giardiasis and in two patients no specific diagnosis
was made. Other reasons for hospitalisation were dengue
fever (n = 1), urinary tract infection (n = 1), infected piloni-
dal sinus (n = 1) and febrile illness with a rash (n = 1). In
three patients the reason for hospitalisation was not
documented. The hospitalization rate was highest in trav-
ellers aged 16-30 years (n = 14, 9 %). Travel style was not
associated with reported rates of hospitalization among
those who presented ill to our clinic (p = 0.07).
Medical assistance and diagnosis in Switzerland
Of the 360 travellers who presented at our clinic, 182
(51 %) did this because of gastrointestinal complaints, 98
(27 %) because of fever and 49 (14 %) because of a skin
problem; 15 (4 %) reported fatigue and six (2 %) mictur-
ition problems. Seven travellers (2 %) requested a check-
up without any complaints. There was no difference in
the frequencies of these main symptoms between sexes
(p = 0.4) nor different age groups (p = 0.8). The median
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Table 1 Characteristics of ill returned travellers according to the region visited
All regions (% of total
travellers)
Latin America (LAM) North Africa Middle East (NAME) Sub-Saharan Africa (SSA) South-east and South
Asia (SESA)
>1 area
Number of travellers 360 83 (23 %) 18 (5 %) 125 (35 %) 128 (36 %) 6 (2 %)
Female sex 212 (59 %) 51 (61 %) 13 (72 %) 75 (60 %) 68 (53 %) 5 (83 %)
Age Group (years)
<30 155 (43 %) 44 (53 %) 8 (44 %) 57 (46 %) 42 (33 %) 4 (67 %)
31 – 64 197 (55 %) 38 (45 %) 10 (56 %) 64 (51 %) 83 (65 %) 2 (33 %)
>64 8 (2 %) 1 (1 %) - 4 (3 %) 3 (2 %) -
Duration of travel (days)
median in d 30 36 14 30 28 91
range in d (5 – 540) (6 – 420) (7 – 60) (5 – 540) (7 – 360) (12 – 191)
≤14 181 (50 %) 34 (41 %) 14 (78 %) 65 (52 %) 67 (52 %) 1 (17 %)
31 – 90 78 (22 %) 24 (29 %) 1 (5 %) 21 (17 %) 31 (24 %) 1 (17 %)
≥91 79 (22 %) 22 (26 %) - 34 (27 %) 20 (16 %) 3 (50 %)
Unknown 22 (6 %) 3 (4 %) 3 (17 %) 5 (4 %) 10 (8 %) 1 (17 %)
Travel Style
Tourism 210 (58 %) 59 (71 %) 13 (72 %) 48 (38 %) 86 (67 %) 4 (67 %)
Close contact to locals 30 (8 %) 4 (5 %) - 19 (15 %) 6 (5 %) 1 (17 %)
Work or study 39 (11 %) 8 (10 %) 1 (6 %) 24 (19 %) 6 (5 %) -
VFR 31 (9 %) 4 (5 %) 2 (11 %) 15 (12 %) 9 (7 %) 1 (17 %)
Unknown 50 (14 %) 8 (10 %) 2 (11 %) 19 (15 %) 21 (16 %) -
Pre-travel health advice 242 (67 %) 60 (72 %) 2 (11 %) 92 (74 %) 82 (64 %) 6 (100 %)
Diarrhoea during journey 200 (56 %) 49 (59 %) 14 (78 %) 79 (63 %) 54 (42 %) 4 (67 %)
Self-reported fever during journey 124 (34 %) 24 (29 %) 5 (28 %) 58 (46 %) 36 (28 %) 1 (17 %)
Presentation because of gastrointestinal
complaints
182 (51 %) 51 (61 %) 12 (67 %) 51 (41 %) 64 (50 %) 4 (67 %)
Unspecific gastrointestinal disorder 129 (36 %) 35 (42 %) 12 (67 %) 32 (26 %) 47 (37 %) 3 (50 %)
Giardiasis 21 (6 %) 4 (5 %) - 9 (7 %) 8 (6 %) -
Amebiasis 14 (4 %) 5 (6 %) - 4 (3 %) 4 (3 %) 1 (17 %)
Salmonellosis (non-typhoidal) 5 (1 %) 3 (4 %) - 1 (<1 %) 1 (<1 %) -
Campylobacteriosis 2 (<1 %) - - 1 (<1 %) 1 (<1 %) -
Shigellosis 4 (1 %) - - 3 (2 %) 1 (<1 %) -
Cyclosporiasis cayetanensis 3 (<1 %) 2 (2 %) - - 1 (<1 %) -
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Table 1 Characteristics of ill returned travellers according to the region visited (Continued)
Typhoid fever 2 (<1 %) - - 1 (<1 %) 1 (<1 %) -
Helminthiasis 2 (<1 %) 2 (2 %) - - - -
Presentation because of fever 98 (27 %) 17 (20 %) 2 (11 %) 42 (34 %) 36 (28 %) 1 (17 %)
Upper respiratory tract infection 44 (12 %) 9 (11 %) 1 (6 %) 13 (10 %) 20 (16 %) 1 (17 %)
Fever with no clinical focus 24 (7 %) 4 (5 %) - 15 (12 %) 5 (4 %) -
Malaria 23 (6 %) 2 (2 %) - 14 (11 %) 7 (5 %) -
Dengue fever 6 (2 %) 1 (1 %) 1 (6 %) - 4 (3 %) -
Tuberculosis 1 (<1 %) 1 (1 %) - - - -
Medical assistance during journey 80 (22 %) 21 (25 %) 1 (6 %) 39 (31 %) 17 (13 %) 2 (33 %)
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time between returning from travel and presentation to
the clinic was 11 days (range 0-313 days, data available
for 321 patients). Thirty-eight percent of all travellers
(n = 138) presented within the first week after returning.
Two-hundred-ninety-one patients (81 %) had a blood
test performed, 179 (50 %) a faecal test and 65 (18 %) a
urine test. Twenty patients (6 %) received an abdominal
ultrasound, 11 (3 %) an X-ray and six (2 %) a CT scan.
Nine patients had a skin smear and three patients a
sputum examination. Only a very small number of pa-
tients needed an invasive procedure, such as skin biopsy
(n = 3), pleural biopsy (n = 1), cerebrospinal fluid analysis
(n = 1), gastroscopy (n = 2) or colonoscopy (n = 2).
A total of 502 stool samples from 179 patients were ana-
lysed. On those samples 363 microscopic tests, 121 cultures,
293 Giardia lamblia-antigen tests, 24 Cryptosporidium-
antigen tests and 1 Clostridium difficile-antigen test were
performed. The pathogens detected are reported in Table 1.
In 71 % (n= 129) of the patients no pathogen was identified.
Of the 98 patients presenting with fever, the majority
(n = 44, 45 %) were diagnosed with an upper respiratory
tract infection or with fever without focal clinical findings
(n = 24, 24 %). Malaria was diagnosed in 23 patients (24 %
of the febrile patients, 6 % of all patients). The diagnosis
was made on basis of a positive thick smear in 14 patients,
a positive antigen test in 4 patients and both tests positive
in one patient. Nine patients each were infected with Plas-
modium falciparum respectively with Plasmodium vivax/
ovale. In five patients (22 %) malaria was already diagnosed
and treated abroad and no Plasmodium species could be
verified; 61 % (n = 14) of the travellers with malaria had
been to SSA, 16 % of the people travelling as VFR were
diagnosed with malaria, while the rate was only 5 % in the
other travellers (p = 0.02). Six patients (6 %) with fever were
diagnosed with dengue fever, and one patient, returning
from LAM, was diagnosed with tuberculosis.
The majority of patients (n = 212 patients, 59 %) did
not require any treatment, however 12 patients (3 %)
had to be hospitalized for the following reasons: two
with P. vivax/ovale infection, one with P. falciparum in-
fection, two each with bacterial enteritis and respiratory
tract infections, and one each with giardiasis, amebiasis,
pancreatitis, and complicated skin lesions.
Associations with pre-travel advice
The majority of our patients (n = 242, 67 %) had sought
pre-travel advice. The rate was 67 % (n = 140) in tourists,
83 % (n = 25) in travellers with close contact to the popula-
tion, 82 % (n = 32) in people travelling for work or study
and 32 % in VFRs (n = 10). Travellers aged 31-64 years less
often sought pre-travel advice than the other age groups
(p = 0.02). With the exception of those travelling to NAME,
where only two (11 %) had seen a doctor before travelling,
destination had no influence on the percentage of people
seeking pre-travel advice (Table 1). All travellers who vis-
ited more than one region sought pre-travel advice. The
most frequent vaccine distributed prior to the index travel
was against hepatitis A or B (263 travellers, 73 %); 148 trav-
ellers (41 %) were vaccinated against typhoid fever, mainly
with the live attenuated oral vaccine, only ten received the
inactivated parenteral vaccine. 126 travellers (35 %) were
vaccinated against yellow fever, 83 (22 %) against rabies, 28
(7 %) against meningococci, 11 (3 %) against tick-borne en-
cephalitis and 4 (1 %) against Japanese encephalitis. People
Table 2 Proportion and odds ratio of diarrhoea or fever among all illness types according to travel style and duration of travel
Diarrhoea Fever
Total 200 (56 %) Odds ratio compared to tourists 124 (34 %) Odds ratio compared to tourists
Travel style
Tourism (n = 210, 58 %) 109 (52 %) 1 61 (29 %) 1
Close contact to locals (n = 30, 8 %) 22 (73 %) 2.5 (95 % CI 1.1-6.0; p = 0.03) 15 (50 %) 2.4 (95 % CI 1.1-5.3; p = 0.02)
Work or study (n = 39, 11 %) 26 (67 %) 1.9 (95 % CI 0.9-3.8; p = 0.09) 18 (46 %) 2.1 (95 % CI 1.0-4.1; p = 0.04)
VFR (n = 31, 9 %) 12 (39 %) 0.6 (95 % CI 0.3-1.3; p = 0.17) 12 (39 %) 1.5 (95 % CI 0.7-3.4; p = 0.28)
Unknown (n = 50, 14 %) 31 (62 %) 1.5 (95 % CI 0.8-2.8; p = 0.20) 18 (36 %) 1.4 (95 % CI 0.7-2.6; p = 0.34)
Duration of travel (in days) Odds ratio compared to≤ 14 days Odds ratio compared to≤ 14 days
≤14 (n = 67, 19 %) 31 (46 %) 1 17 (25 %) 1
15 - 30 (n = 107, 30 %) 53 (50 %) 1.1 (95 % CI 0.6-2.1; p = 0.67) 29 (27 %) 1.1 (95 % CI 0.6-2.2; p = 0.81)
31 – 60 (n = 60, 17 %) 33 (55 %) 1.4 (95 % CI 0.7-2.9; p = 0.32) 26 (43 %) 2.3 (95 % CI 1.1-4.8; p = 0.03)
61 - 90 (n = 24, 6 %) 15 (63 %) 1.9 (95 % CI 0.7-5.0; p = 0.17) 13 (54 %) 3.5 (95 % CI 1.3-9.2; p = 0.01)
91 - 364 (n = 65, 18 %) 46 (71 %) 2.8 (95 % CI 1.4-5.8; p < 0.01) 28 (43 %) 2.2 (95 % CI 1.1-4.7; p = 0.03)
≥365 (n = 13, 4 %) 10 (77 %) 3.9 (95 % CI 1.0-15.3; p = 0.04) 6 (46 %) 2.5 (95 % CI 0.7-8.6; p = 0.121)
Unknown (n = 24, 6 %) 12 (50 %) 5 (21 %)
1Fisher’s exact
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who had sought pre-travel advice showed higher vaccin-
ation coverage than those without pre-travel advice: 78 %
versus 12 % (p < 0.01) were vaccinated against hepatitis A,
42 % versus 21 % (p < 0.01) against hepatitis A and B, 52 %
versus 11 % (p = 0.01) against typhus, 48 % versus 9 %
against yellow fever (p < 0.01) and 32 % versus 3 % (p <
0.01) against rabies.
Since the exact travel routes were not documented, it
was not possible to evaluate how many persons travelled to
malaria-endemic areas and should have taken malaria
prophylaxis following current recommendations. One third
of the ill-returning travellers (n = 110, 31 %) took malaria
prophylaxis; those who had sought pre-travel advice did
this significantly more frequently than those who had not
(OR 7.6 95 % CI 3.8-15.3; p < 0.01). Of the 125 travellers
going to SSA, 79 % (n = 87) had taken prophylaxis (pre-
travel advice: 83 %; no pre-travel advice: 33 %). Fifty-six
travellers (16 %) had carried malaria stand-by medication,
mostly travellers to LAM (n = 30) or SESA (n = 23); this is
in line with Swiss recommendations. Again, people with
pre-travel advice were more likely to carry malaria stand-
by medication on their trip. Among patients presenting
with a travel related illness, those diagnosed with malaria
reported having sought pre-travel medical advice less
frequently compared to those with conditions other than
malaria (OR 0.2; 95 % CI 0.1-0.5; p < 0.01). Further, among
patients presenting with a travel related illness, those
who had required self-administered drugs or medical as-
sistance abroad reported having had pre-travel advice less
often than those who had not required drugs (OR for hav-
ing had pre-travel advice 0.5; 95 % CI 0.3-0.96; p = 0.03) or
medical assistance abroad (OR 0.1; 95 % CI 0.1-0.2; p <
0.01). However, among these ill returning travellers, there
was no difference in use of pre-travel advice in those pre-
senting with diarrhoea or fever (p > 0.05 for both).
Discussion
This study analyses travellers returning ill from the tropics
and presenting to a Swiss outpatient tertiary care clinic.
The main symptoms leading to a post-travel consultation
were gastrointestinal complaints and fever. People who
travelled for longer durations or had close contact to the
population were more likely to return with a complaint of
fever and diarrhoea compared to other chief complaints,
while VFRs were not at higher risk of presenting for these
conditions. It has been reported before that the propor-
tionate rates of acute diarrhoea is lower in VFR in another
Swiss study with a similar population [11].
The majority of gastrointestinal and febrile disorders
(69 % each) remained without detection of a specific
etiological agent. Specific antimicrobial treatment was
administered to one third of the travellers. Nine percent
of travellers were diagnosed with a potentially life-
threatening condition, of which six percent suffered
from malaria. Among the seven travellers diagnosed
with malaria abroad, all stated to have been adherent
with chemoprophylaxis provided. Whether this was at-
tributable to misdiagnosis, recall bias, or breakthrough
malaria could not be verified retrospectively. Malaria
was a more frequent diagnosis in VFRs compared to
other traveller types. Similar findings have been ob-
served in larger surveillance studies where VFRs pre-
sented with malaria up to eight times more often than
regular tourists [12–14].
The destination of travel was associated with specific
diseases at presentation to the clinic. Systemic febrile ill-
ness with no clinical focus and malaria occurred most
often in travellers returning from SSA; upper respiratory
tract infections in travellers returning from SSA and
SESA. Unspecific gastrointestinal disorders occurred
with equal frequency in people returning from LAM,
SSA and SESA. Our results are consistent with GeoSen-
tinel and EuroTravNet based studies where systemic fe-
brile illness and malaria occurred more often among
travellers returning from SSA and SESA and diarrheal
illness was most commonly seen among those returning
from SSA, LAM and SESA [4, 7, 8]. Among those
reporting illnesses associated with diarrhoea or fever,
there was no difference in the rate reporting pre-travel
advice compared to other illnesses. As expected, those
who reported pre-travel advice had significantly higher
vaccination coverage and use of malaria medication,
both as prophylaxis and as stand-by options, and lower
rates of self-administered medication or medical assist-
ance abroad. In the study by Schlagenhauf et al, pre-
travel advice also significantly reduced the proportionate
morbidity of malaria, but was associated with an in-
crease in diarrhoea [8].
The results of our study are limited by the small num-
bers and because data was only collected at one centre.
Further, the results are subject to bias due to the retro-
spective design. As usual for such type of study there is a
lack of denominator data from returning healthy travellers
to inform true risk associations and therefore data is only
descriptive. Also there were limitations in the detection of
pathogens, especially from stool samples, because culture-
independent methods like immunoassays and PCRs were
only performed when explicitly asked for by the physician.
The strengths of the study are the focus on and descrip-
tion of the pragmatic approach in a clinical setting without
an a priori research agenda.
To summarize, this study reflects the pragmatic ap-
proach to returning ill travellers in Switzerland, where
health insurance is compulsory, but the per capita
monthly insurance premium can be chosen individually.
The lower the monthly premium, the higher are the
yearly costs that the patients have to pay out of their
own pocket. Frequently patients with lower monthly
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premiums therefore opt not to have all analyses done if
no practical consequences are likely to ensue from a re-
sult. This is typically the case in returning travellers with
uncomplicated (afebrile, non-bloody) diarrhea or with
fever and symptoms of a viral infection of the upper re-
spiratory tract once malaria and dengue have been ruled
out. In these patients the academic drive towards finding
the causative pathogen is overruled by practical consider-
ations of the financial implications of further diagnostics
that are not likely to change therapeutical management.
Apart from VFR travellers as a known at-risk population
for malaria, our study has also identified non-VFR travel-
lers engaging in close contacts with the local population
to be at increased risk for diarrheal illness and fever. Even
though the majority of illnesses in returning travellers are
gastrointestinal symptoms of mild to moderate severity
and a specific etiological is often not identified, malaria
remains the most frequent potentially life-threatening
disease in returning ill travellers. In patients presenting to
our clinic with malaria or reporting the need for treatment
or hospitalisation abroad, pre-travel advice had been more
frequently omitted than sought – this may suggest a pro-
tective effect of pre-travel advice for these selected travel-
related problems.
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